ArticleScience China. Life sciences2026
AI-decoded enzymatic blueprints navigate the unknown metabolome.
Shu-Xin Cao, Xiang Luo, Yu Bai, Hong-Li Tan, Rong-Rong He
Abstract read
In one paragraphArticle in Science China. Life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors.
Shu-Xin CaoState Key Laboratory of Bioactive Molecules and Druggability Assessment/Guangdong Engineering Research Center of Traditional Chinese Medicine & Disease Susceptibility/International Cooperative Laboratory of TCM Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE)/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy/College of TCM, Jinan University, Guangzhou, 510632, China.
Xiang LuoState Key Laboratory of Bioactive Molecules and Druggability Assessment/Guangdong Engineering Research Center of Traditional Chinese Medicine & Disease Susceptibility/International Cooperative Laboratory of TCM Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE)/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy/College of TCM, Jinan University, Guangzhou, 510632, China.
Yu BaiDepartment of Electrical and Computer Engineering, California State University, Fullerton, 92831, USA.
Hong-Li TanState Key Laboratory of Bioactive Molecules and Druggability Assessment/Guangdong Engineering Research Center of Traditional Chinese Medicine & Disease Susceptibility/International Cooperative Laboratory of TCM Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE)/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy/College of TCM, Jinan University, Guangzhou, 510632, China. honglitan@jnu.edu.cn.
Rong-Rong HeState Key Laboratory of Bioactive Molecules and Druggability Assessment/Guangdong Engineering Research Center of Traditional Chinese Medicine & Disease Susceptibility/International Cooperative Laboratory of TCM Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE)/Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, College of Pharmacy/College of TCM, Jinan University, Guangzhou, 510632, China. rongronghe@jnu.edu.cn.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
What OpenQuestion holds
Textmetadata
Read underepoch 390